期刊文献+

造血干细胞移植患者的输血问题 被引量:3

原文传递
导出
摘要 造血干细胞移植(hematopoietic stem cell transplantation,HSCT)患者在造血重建前将出现全血细胞减少,时间可持续约2周或更长。在预处理、移植及移植后,HSCT患者可能因贫血、出血而需要输注红细胞、血小板、血浆等血液成分。
作者 李贝 秦莉
出处 《诊断学理论与实践》 2015年第6期502-506,共5页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献22

  • 1Raimondi R, Soli M, Lamparelli T, Bacigalupo A, et al. ABO-incompatible bone marrow transplantation: a GIT- MO survey of current practice in Italy and comparison with the literature[J]. Bone Marrow Transplant,2004,34(4): 321-329.
  • 2Remberger M, Watz E, Ringdrn O, et al. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant,2007,13(6):675-682.
  • 3Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity[J]. Transfusion, 1999,39(11- 12): 1273 - 1274.
  • 4Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation [J]. Transfusion,2003,43(8): 1153-1161.
  • 5Stussi G, Muntwyler J, Passweg JR, et al.Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant,2002,30(2): 87-93.
  • 6Resnick IB, Tsirigotis PD, Shapira MY, et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients[J]. Biol Blood Marrow Transplant,2008,14(4):409-417.
  • 7Sieff C, Bicknell D, Caine G, et al. Changes in cell surface antigen expression during hemopoietic differentiation [J]. Blood, 1982,60(3):703-713.t.
  • 8Maeiej Zaueha J, Mielearek M, Takatu A, et al. Engrafment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation[J]. Br J Haematol,2002,119(3): 740-750.
  • 9Marenchino D, Maddalena L, Balbo R, et al. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning[J]. Blood Transfus,2011,9(1):79-85.
  • 10高志勇,谢毅.血型不合造血干细胞移植前后的输血支持[J].中国输血杂志,2010,23(6):417-419. 被引量:4

二级参考文献6

  • 1Pamphilon DH. Rransfusion policy//Apperley J, Carreras E, Gluekman E, et al. The EBMT handbook, Haematopoietic Stem Cell Transplantation. 5th ed Paris: European School of Haematology,2008 : 146-160.
  • 2Dodds AJ. ABO incompatibility and blood product support//Atkinson K, Champlin R, Ritz J, et al. Clinical bone marrow and blood stem cell transplantation. 3rd ed,2004: 1077-1086.
  • 3McCullough J. Principles of transfusion support before and after hematopoietic cell transplantation//Blume KG, Forman SJ, Appelbaum FR, et al. Thomas' hematopoietic cell transplantation. 3rd ed, 2004: 833-846.
  • 4Transfusion biology and therapy ,//Harser FBK and Loscalzo LJ, Harrison's principles of internal medicine. 17th ed. New Nork: McGraw-Hill Companies, 2008.
  • 5Klein HG, Dzik WH, Strauss RG, et al. Leukocyte-reduced blood component therapy//Hematology-1992. The education program of The American Society of Hematology: 76-85.
  • 6Leitman SF, Holland PV. Irradiation of blood products: indications and guidelines. Transfusion, 1985, 25(4): 293-303.

共引文献3

同被引文献14

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部